BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6981637)

  • 21. Recognition of HLA-B27 and related antigen by a monoclonal antibody.
    Ellis SA; Taylor C; McMichael A
    Hum Immunol; 1982 Aug; 5(1):49-59. PubMed ID: 6981636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-B27, Klebsiella, and ankylosing spondylitis.
    Geczy AF; Yap J
    Lancet; 1979 Mar; 1(8118):719-20. PubMed ID: 85952
    [No Abstract]   [Full Text] [Related]  

  • 23. The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary.
    Prendergast JK; Sullivan JS; Geczy AF; Upfold LI; Edmonds JP; Bashir HV
    Hum Immunol; 1984 Mar; 9(3):131-6. PubMed ID: 6365855
    [No Abstract]   [Full Text] [Related]  

  • 24. A reinvestigation of the cross-reactivity between Klebsiella and HLA-B27 in the aetiology of ankylosing spondylitis.
    Georgopoulos K; Dick WC; Goodacre JA; Pain RH
    Clin Exp Immunol; 1985 Dec; 62(3):662-71. PubMed ID: 3878755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Cross-reactivity studies with rabbit antisera.
    Welsh J; Avakian H; Cowling P; Ebringer A; Wooley P; Panayi G; Ebringer R
    Br J Exp Pathol; 1980 Feb; 61(1):85-91. PubMed ID: 6769456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regarding the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Terasaki PI; Yu DT
    Arthritis Rheum; 1987 Mar; 30(3):353-4. PubMed ID: 3551967
    [No Abstract]   [Full Text] [Related]  

  • 27. Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis.
    McGuigan LE; Prendergast JK; Geczy AF; Edmonds JP; Bashir HV
    Ann Rheum Dis; 1986 Jul; 45(7):566-71. PubMed ID: 3527085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-B27, molecular mimicry, and ankylosing spondylitis: popular misconceptions.
    Geczy AF; Prendergast JK; Sullivan JS; Upfold LI; McGuigan LE; Bashir HV; Prendergast M; Edmonds JP
    Ann Rheum Dis; 1987 Feb; 46(2):171-2. PubMed ID: 3493737
    [No Abstract]   [Full Text] [Related]  

  • 29. Cross-reactivity of anti-Klebsiella K43 BTS 1 serum and lymphocytes of patients with ankylosing spondylitis: antipodean curiosity?
    Geczy AF; Prendergast JK; McGuigan LE; Upfold LI; Sullivan JS
    Lancet; 1985 May; 1(8438):1169. PubMed ID: 2860379
    [No Abstract]   [Full Text] [Related]  

  • 30. Ankylosing spondylitis syndrome in patients without HLA-B27.
    Jajić I; Kerhin V; Kastelan A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):136. PubMed ID: 6606465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased frequency of HLA-Bw35 CREG antigens in HLA-B27 negative ankylosing spondylitis.
    Wagener P; Zeidler H; Eckert G; Deicher H
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):134-5. PubMed ID: 6606464
    [No Abstract]   [Full Text] [Related]  

  • 32. Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay.
    Sakaguchi K; Ono R; Tsujisaki M; Richiardi P; Carbonara A; Park MS; Tonai R; Terasaki PI; Ferrone S
    Hum Immunol; 1988 Mar; 21(3):193-207. PubMed ID: 3259570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of ankylosing spondylitis: the state of the art.
    Calin A
    Br J Rheumatol; 1988; 27 Suppl 2():106-9. PubMed ID: 3042068
    [No Abstract]   [Full Text] [Related]  

  • 34. The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis.
    Ebringer A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):53-66. PubMed ID: 6418259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to the editorial by Terasaki and Yu on the ankylosing spondylitis/Klebsiella/HLA-B27 problem.
    Geczy AF; Sullivan JS; McGuigan LE
    Arthritis Rheum; 1987 Jun; 30(6):714-5. PubMed ID: 3300661
    [No Abstract]   [Full Text] [Related]  

  • 36. Expression of HLA-B27 antigens on mononuclear leucocytes in ankylosing spondylitis.
    van der Gaag R; Luyendijk L; Linssen A; Kijlstra A
    Clin Exp Immunol; 1985 May; 60(2):311-5. PubMed ID: 3874023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B27 and ankylosing spondylitis in the Mexican Mestizo population.
    Arellano J; Vallejo M; Jimenez J; Mintz G; Kretschmer RR
    Tissue Antigens; 1984 Feb; 23(2):112-6. PubMed ID: 6608804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ankylosing spondylitis, HLA-B27, and klebsiella.
    Geczy AF
    Ann Rheum Dis; 1986 Mar; 45(3):261-2. PubMed ID: 3485411
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA antigens as carrier molecules.
    van Rood JJ
    Hum Immunol; 1986 Nov; 17(3):246-9. PubMed ID: 3491813
    [No Abstract]   [Full Text] [Related]  

  • 40. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study.
    van der Linden S; Valkenburg H; Cats A
    Br J Rheumatol; 1983 Nov; 22(4 Suppl 2):18-9. PubMed ID: 6606472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.